Home / Our research / Cancer Genetics Adrenal Laboratory 

Professor Bruce Gregory Robinson

Professor and Dean
Medicine, Northern Clinical School
Kolling Institute of Medical Research

A27 - Edward Ford Building
The University of Sydney
NSW 2006 Australia

T:+61 2 9926 7267 or 9351 6570
F:+61 2 9926 8523 or 9351 3196
E:

Research interests

Professor Robinson is an Endocrinologist and has been Head of the Molecular Genetics Unit, (now Cancer Genetics Unit) at the Kolling Institute of Medical Research, Royal North Shore Hospital since 1989.

His research has focused on identifying the genetic causes contributing to the formation of tumours in endocrine glands such as the thyroid, parathyroid, adrenal and pituitary. Initially this commenced with identification of mutations in genes causing hereditary endocrine syndromes such as multiple endocrine neoplasia type 2, and subsequently hyperparathyroidism jaw tumour syndrome and the hereditary phaeochromocytoma/paraganglioma syndromes.

He recently formed the International SDH Consortium gathering families from around the world to define the relationships between phaeochromocytoma / paraganglioma and the SDH genes. In addition his lab has characterised mutations and their consequences in sporadic tumours of the thyroid adrenal and recently in brain tumours.

Since 2001 he has been the Chairman of Hoc Mai, the University of Sydney's Australia Vietnam Medical Foundation. He has supervised 25 PhD students.

Back to Top

Publications

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

2009

  
  • Meyer-Rochow, G., Smith, J., Richardson, A., Marsh, D., Sidhu, S., Robinson, B., Benn, D. Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma. The Journal of surgical research. 2009; 157:55-62. [Abstract]
  • Soon, P., Gill, A., Benn, D., Clarkson, A., Robinson, B., McDonald, K., Sidhu, S. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumours identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocrine-related cancer. 2009; 16:573-83. [Abstract]
  • Meyer-Rochow, G., Soon, P., Delbridge, L., Sywak, M., Bambach, C., Clifton-Bligh, R., Robinson, B., Sidhu, S. Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ Journal of Surgery. 2009; 79:367-370. [Abstract]
  • Meyer-Rochow, G., McMullen, T., Gill, A., Sywak, M., Robinson, B. Intra-abdominal insular thyroid carcinoma metastasis. Thyroid. 2009; 19:527-530. [Abstract]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. The Journal of clinical Endocrinology and Metabolism. 2009; 94:1436-1442. [Abstract]
  • Howell, V., Gill, A., Clarkson, A., Nelson, A., Dunne, R., Delbridge, L., Robinson, B., Teh, B., Gimm, O., Marsh, D. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. The Journal of clinical endocrinology and metabolism. 2009; 94:434-41. [Abstract]
  • Warusavitarne, J., McDougall, F., de Silva, K., Barnetson, R., Messina, M., Robinson, B., Schnitzler, M. Restoring TGFbeta function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation. International journal of colorectal disease. 2009; 24:139-44. [Abstract]
  • Figtree, G., Robinson, B., Channon, K., Watkins, H. Polymorphism upstream of estrogen receptor alpha reverses negative regulation of transcription. International journal of cardiology. 2009; 0:0. [Abstract]
  • Figtree, G., Guzik, T., Robinson, B., Channon, K., Watkins, H. Functional estrogen receptor alpha promoter polymorphism is associated with improved endothelial-dependent vasolidation. International Journal of Cardiology. 2009; 0:0. [Abstract]
  • Learoyd, D., Robinson, B. Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer. Nature clinical practice. Endocrinology & metabolism. 2009; 5:6-7. [Abstract]

2008

  
Back to Top
  • Grodski, S., Brown, T., Sidhu, S., Gill, A., Robinson, B., Learoyd, D., Sywak, M., Reeve, T., Delbridge, L. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008; 144:1038-1043. [Abstract]
  • Low, T., Delbridge, L., Sidhu, S., Learoyd, D., Robinson, B., Roach, P., Sywak, M. Lymph Node Status Influences Follow-Up Thyroglobulin Levels in Papillary Thyroid Cancer. Annals of surgical oncology. 2008; 15:2827-32. [Abstract]
  • Kim, L., Holland, A., Srinivasan, S., Cowell, C., Benn, D., Robinson, B. Paediatric bilateral adrenal phaeochromocytomas in association with a novel mutation in the von Hippel Lindau gene. Journal of paediatrics and child health. 2008; 44:514-516. [Abstract]
  • Lee, J., Au, A., Foukakis, T., Barbaro, M., Kiss, N., Clifton-Bligh, R., Staaf, J., Borg, A., Delbridge, L., Robinson, B., Wallin, G., Höög, A., Larsson, C. Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocrine-related Cancer. 2008; 15:801-815. [Abstract]
  • Figtree, G., Grieve, S., Speller, B., Geiger, M., Robinson, B., Channon, K., Ragoussis, J., Collins, P., Watkins, H. A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL. Atherosclerosis. 2008; 199:354-61. [Abstract]
  • Adler, J., Meyer-Rochow, G., Chen, H., Benn, D., Robinson, B., Sippel, R., Sidhu, S. Pheochromocytoma: current approaches and future directions. The oncologist. 2008; 13:779-793. [Abstract]
  • Soon, P., McDonald, K., Robinson, B., Sidhu, S. Molecular markers and the pathogenesis of adrenocortical cancer. The Oncologist. 2008; 13:548-561. [Abstract]
  • Grodski, S., Gill, A., Robinson, B., Sidhu, S. Nonfunctioning parathyroid cancer presenting as a cervical mass. Thyroid. 2008; 18:473-474. [Abstract]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Shaw, J., Law, A., Cook, R., Little, N., Clifton-Bligh, R., Robinson, B., McDonald, K. Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology. 2008; 149:1235-42. [Abstract]
  • Learoyd, D., Robinson, B. Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases?. Nature clinical practice. Endocrinology & metabolism. 2008; 4:132-3. [Abstract]
  • Parkinson, J., Wheeler, H., Clarkson, A., McKenzie, C., Biggs, M., Little, N., Cook, R., Messina, M., Robinson, B., McDonald, K. Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. Journal of neuro-oncology. 2008; 87:71-8. [Abstract]
  • Soon, P., Libe, R., Benn, D., Gill, A., Shaw, J., Sywak, M., Groussin, L., Bertagna, X., Gicquel, C., Bertherat, J., McDonald, K., Sidhu, S., Robinson, B. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Annals of Surgery. 2008; 247:157-164. [Abstract]
  • Soon, P., Yeh, M., Delbridge, L., Bambach, C., Sywak, M., Robinson, B., Sidhu, S. Laparoscopic surgery is safe for large adrenal lesions. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008; 34:67-70. [Abstract]

2007

  
Back to Top
  • Lundgren, C., Delbridg, L., Learoyd, D., Robinson, B. Surgical approach to medullary thyroid cancer. Arquivos brasileiros de endocrinologia e metabologia. 2007; 51:818-824. [Abstract]
  • McDonald, K., O'Sullivan, M., Parkinson, J., Shaw, J., Payne, C., Brewer, J., Young, L., Reader, D., Wheeler, H., Cook, R., Biggs, M., Little, N., Teo, C., Stone, G., Robinson, B. IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. Journal of neuropathology and experimental neurology. 2007; 66:405-417. [Abstract]
  • Yan, W., Roach, P., Bautovich, G., Learoyd, D., Robinson, B. Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma. Clinical nuclear medicine. 2007; 32:375-377. [Abstract]
  • Soon, P., Benn, D., Gill, A., Robinson, B., McDonald, K. Es07 microarray gene expression analysis of human adrenocortical tumours. Australia: Blackwell Publishing Asia, 2007. [Abstract]
  • Messina, M., Robinson, B. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma. Nature clinical practice. Endocrinology & metabolism. 2007; 3:290-301. [Abstract]
  • Figtree, G., Kindmark, A., Lind, L., Grundberg, E., Speller, B., Robinson, B., Channon, K., Watkins, H. Novel estrogen receptor alpha promoter polymorphism increases ventricular hypertrophic response to hypertension. The Journal of steroid biochemistry and molecular biology. 2007; 103:110-8. [Abstract]
  • Grodski, S., Stalberg, P., Robinson, B., Delbridge, L. Surgery versus Radioiodine Therapy as Definitive Management for Graves' Disease: The Role of Patient Preference. Thyroid : official journal of the American Thyroid Association. 2007; 17:157-160. [Abstract]
  • Benn, D., Robinson, B. Pheochromocytoma - quo vadis?. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM. 2007; 3:377-377. [Abstract]

2006

  
Back to Top
  • Clarke, J., Patel, S., Raymond, R., Andrew, S., Robinson, B., Dressler, G., Brophy, P. Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. Human molecular genetics. 2006; 15:3420-8. [Abstract]
  • Howell, V., Cardinal, J., Richardson, A., Gimm, O., Robinson, B., Marsh, D. Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism. The Journal of molecular diagnostics : JMD. 2006; 8:559-66. [Abstract]
  • Warusavitarne, J., Ramanathan, P., Kaufman, A., Robinson, B., Schnitzler, M. 5-Fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. International journal of colorectal disease. 2006; 21:625-31. [Abstract]
  • Benn, D., Robinson, B. Genetic basis of phaeochromocytoma and paraganglioma. Best practice & research. Clinical endocrinology & metabolism. 2006; 20:435-50. [Abstract]
  • Benn, D., Richardson, A., Marsh, D., Robinson, B. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Annals of the New York Academy of Sciences. 2006; 1073:104-11. [Abstract]
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone. 2006; 39:369-76. [Abstract]
  • Bolland, M., Benn, D., Croxson, M., McCall, J., Shaw, J., Baillie, T., Robinson, B. Gastrointestinal stromal tumour in succinate dehydrogenase subunit B mutation-associated familial phaeochromocytoma/paraganglioma. Anz Journal of Surgery. 2006; 76:763A-764. [Abstract]
  • Gosnell, J., Sywak, M., Sidhu, S., Gough, I., Learoyd, D., Robinson, B., Delbridge, L. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ journal of surgery. 2006; 76:586-90. [Abstract]
  • Stalberg, P., Sidhu, S., Sywak, M., Robinson, B., Wilkinson, M., Delbridge, L. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making?. Journal of the American College of Surgeons. 2006; 203:1-6. [Abstract]
  • Sundram, F., Robinson, B., Kung, A., Lim-Abrahan, M., Bay, N., Chuan, L., Chung, J., Huang, S., Hsu, L., Kamaruddin, N., Cheah, W., Kim, W., Koong, S., Da Lin, H., Mangklabruks, A., Paz-Pacheco, E., Rauff, A., Ladenson, P. Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline. Thyroid. 2006; 16:461-469. [Abstract]
  • Palazzo, F., Gosnell, J., Savio, R., Reeve, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2006; 32:340-4. [Abstract]
  • Giordano, T., Au, A., Kuick, R., Thomas, D., Rhodes, D., Wilhelm, K., Vinco, M., Misek, D., Sanders, D., Zhu, Z., Ciampi, R., Hanash, S., Chinnaiyan, A., Clifton-Bligh, R., Robinson, B., Nikiforov, Y., Koenig, R. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical Cancer Research. 2006; 12:1983-1993. [Abstract]
  • Benn, D., Gimenez-Roqueplo, A., Reilly, J., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P., Elston, M., Gimm, O., Henley, D., Herman, P., Murday, V., Niccoli-Sire, P., Pasieka, J., Rohmer, V., Tucker, K., Jeunemaitre, X., Marsh, D., Plouin, P., Robinson, B. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism. 2006; 91:827-836. [Abstract]
  • Warner, J., Nyholt, D., Busfield, F., Epstein, M., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., Teh, B., Prins, J., Cardinal, J. Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. Journal of Medical Genetics. 2006; 43:0. [Abstract]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR gamma fusion. Journal of Clinical Endocrinology and Metabolism. 2006; 91:1143-1149. [Abstract]
  • Benn, D., Gimenez-Roqueplo, A., Reilly, J., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P., Elston, M., Gimm, O., Henley, D., Herman, P., Murday, V., Niccoli-Sire, P., Pasieka, J., Rohmer, V., Tucker, K., Jeunemaitre, X., Marsh, D., Plouin, P., Robinson, B. Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes. The Journal of clinical endocrinology and metabolism. 2006; 91:827-36. [Abstract]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. The Ras Effector NORE1A is Suppressed in Follicular Thyroid Carcinomas with a PAX8-PPAR{gamma} Fusion. The Journal of clinical endocrinology and metabolism. 2006; 91:1143-9. [Abstract]
  • Elston, M., Benn, D., Robinson, B., Conaglen, J. An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years. Internal Medicine Journal. 2006; 36:129-131. [Abstract]
  • Taylor, J., Gough, S., Hunt, P., Brix, T., Chatterjee, K., Connell, J., Franklyn, J., Hegedus, L., Robinson, B., Wiersinga, W., Wass, J., Zabaneh, D., Mackay, I., Weetman, A. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism. 2006; 91:646-653. [Abstract]
  • Au, A., McBride, C., Wilhelm, K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology. 2006; 147:367-76. [Abstract]

2005

  
Back to Top
  • Learoyd, D., Gosnell, J., Elston, M., Saurine, T., Richardson, A., Delbridge, L., Aglen, J., Robinson, B. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clinical endocrinology. 2005; 63:636-41. [Abstract]
  • Learoyd, D., Robinson, B. Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery?. Nature Clinical Practice Endocrinology & Metabolism. 2005; 1:60-61. [Abstract]
  • Dechairo, B., Zabaneh, D., Collins, J., Brand, O., Dawson, G., Green, A., Mackay, I., Franklyn, J., Connell, J., Wass, J., Wiersinga, W., Hegedus, L., Brix, T., Robinson, B., Hunt, P., Weetman, A., Carey, A., Gough, S. Association of the TSHR gene with Graves'' disease: the first disease specific locus. European Journal of Human Genetics. 2005; 13:1223-1230. [Abstract]
  • Savio, R., Gosnell, J., Palazzo, F., Sywak, M., Agarwal, G., Cowell, C., Shun, A., Robinson, B., Delbridge, L. The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children. Journal of pediatric surgery. 2005; 40:1696-700. [Abstract]
  • Figtree, G., Robinson, B., Channon, K., Watkins, H. Novel polymorphism in estrogen receptor alpha reverses negative transcriptional regulation and is associated with improved endothelial-dependent vasodilation. Circulation. 2005; 112:U57-U57. [Abstract]
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Nelson, A., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. Elevated serum FGF23 concentrations in plasma cell dyscrasias. Journal of Bone and Mineral Research. 2005; 20:S116-S116. [Abstract]
  • Alderazi, Y., Yeh, M., Robinson, B., Benn, D., Sywak, M., Learoyd, D., Delbridge, L., Sidhu, S. Phaeochromocytoma: current concepts. Medical Journal of Australia. 2005; 183:201-4. [Abstract]
  • Shaw, J., Messina, M., Both, G., Molloy, P., Robinson, B. Transcription targeted gene therapy for medullary thyroid carcinoma. Journal of Gene Medicine. 2005; 7:1126-1127. [Abstract]
  • Dahia, P., Ross, K., Wright, M., Hayashida, C., Santagata, S., Barontini, M., Kung, A., Sanso, G., Powers, J., Tischler, A., Hodin, R., Heitritter, S., Moore, F., Dluhy, R., Sosa, J., Ocal, I., Benn, D., Marsh, D., Robinson, B., Schneider, K., Garber, J., Arum, S., Korbonits, M., Grossman, A., Pigny, P., Toledo, S., Nose, V., Li, C., Stiles, C. A HIF1 alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. Plos Genetics. 2005; 1:72-80. [Abstract]
  • Harding, J., Yeh, M., Robinson, B., Delbridge, L., Sidhu, S. Potential pitfalls in the diagnosis of phaeochromocytoma. The Medical journal of Australia. 2005; 182:637-40. [Abstract]
  • Sidhu, S., Martin, E., Gicquel, C., Melki, J., Clark, S., Campbell, P., Magarey, C., Schulte, K., Röher, H., Delbridge, L., Robinson, B. Mutation and methylation analysis of TP53 in adrenal carcinogenesis. European journal of surgical oncology. 2005; 31:549-554. [Abstract]
  • Cardinal, J., Bergman, L., Hayward, N., Sweet, A., Warner, J., Marks, L., Learoyd, D., Dwight, T., Robinson, B., Epstein, M., Smith, M., Teh, B., Cameron, D., Prins, J. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of medical genetics. 2005; 42:69-74. [Abstract]
  • Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Stalley, P., Bonar, S., Yu, D., Pollock, R., Reddel, R. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical cancer research. 2005; 11:217-25. [Abstract]

2004

  
Back to Top
  • Mirams, M., Robinson, B., Mason, R., Nelson, A. Bone as a source of FGF23: regulation by phosphate?. Bone. 2004; 35:1192-9. [Abstract]
  • Haven, C., Howell, V., Eilers, P., Dunne, R., Takahashi, M., van Puijenbroek, M., Furge, K., Kievit, J., Tan, M., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Nelson, A., Krause, U., Dralle, H., Hoang-Vu, C., Gimm, O., Morreau, H., Marsh, D., Teh, B. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer research. 2004; 64:7405-11. [Abstract]
  • McDonnell, C., Benn, D., Marsh, D., Robinson, B., Zacharin, M. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma. Clinical endocrinology. 2004; 61:510-4. [Abstract]
  • Howell, V., Zori, R., Stalker, H., Williams, C., Jesse, N., Nelson, A., Robinson, B., Marsh, D. A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones. The Journal of pediatrics. 2004; 145:567. [Abstract]
  • Parker, D., Robinson, B., O'Donnell, B. External ophthalmic findings in multiple endocrine neoplasia type 2B. Clinical & experimental ophthalmology. 2004; 32:420-3. [Abstract]
  • Chan, S., Nery, L., McElduff, A., Wilmshurst, E., Fulcher, G., Robinson, B., Stiel, J., Gunton, J., Clifton-Bligh, P. Intravenous pamidronate in the treatment and prevention of osteoporosis. Internal medicine journal. 2004; 34:162-6. [Abstract]
  • Villablanca, A., Calender, A., Forsberg, L., Höög, A., Cheng, J., Petillo, D., Bauters, C., Kahnoski, K., Ebeling, T., Salmela, P., Richardson, A., Delbridge, L., Meyrier, A., Proye, C., Carpten, J., Teh, B., Robinson, B., Larsson, C. Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). Journal of medical genetics. 2004; 41:e32. [Abstract]
  • Warner, J., Epstein, M., Sweet, A., Singh, D., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., Birdsey, P., Mackenzie, E., Teh, B., Prins, J., Cardinal, J. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. Journal of medical genetics. 2004; 41:155-60. [Abstract]
  • Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. Adrenocortical cancer: recent clinical and molecular advances. Current opinion in oncology. 2004; 16:13-8. [Abstract]
  • Robinson, B., Figtree, G. Estrogen receptor polymorphisms in common disease:recent developments. Current Opinion in Endocrinology and diabetes. 2004; 11:141-146.
  • Yamazaki, M., Straus, F., Messina, M., Robinson, B., Takeda, T., Hashizume, K., DeGroot, L. Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma. Cancer gene therapy. 2004; 11:8-15. [Abstract]
  • Teh, B., Howell, V., Haven, C., Kahnoski, K., Khoo, S., Petillo, D., Chen, J., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Nelson, A., Krause, U., Hammje, K., Dralle, H., Hoang-Vu, C., Gimm, O., Marsh, D., Morreau, H. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome. Human genetics. 2004; 114:221-224. [Abstract]

2003

  
Back to Top
  • Sambrook, P., Hughes, D., Nelson, A., Robinson, B., Mason, R. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the rheumatic diseases. 2003; 62:1215-1217. [Abstract]
  • Barnetson, R., Eckstein, R., Robinson, B., Schnitzler, M. There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas with microsatellite instability. Genes, chromosomes & cancer. 2003; 38:149-56. [Abstract]
  • Nelson, A., Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jüppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., Bligh, P. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. The Journal of clinical endocrinology and metabolism. 2003; 88:4088-4094. [Abstract]
  • Howell, V., Haven, C., Kahnoski, K., Khoo, S., Petillo, D., Chen, J., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Nelson, A., Krause, U., Hammje, K., Dralle, H., Hoang-Vu, C., Gimm, O., Marsh, D., Morreau, H., Teh, B. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of medical genetics. 2003; 40:657-63. [Abstract]
  • Freeman, M., Roach, P., Robinson, B., Shields, M. Hiatal hernia in iodine-131 scintigraphy: a potential cause of false-positive midline thoracic uptake. Clinical nuclear medicine. 2003; 28:709-10. [Abstract]
  • Marsh, D., Theodosopoulos, G., Martin-Schulte, K., Richardson, A., Philips, J., Röher, H., Delbridge, L., Robinson, B. Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma. The Journal of clinical endocrinology and metabolism. 2003; 88:1866-72. [Abstract]
  • Benn, D., Croxson, M., Tucker, K., Bambach, C., Richardson, A., Delbridge, L., Pullan, P., Hammond, J., Marsh, D., Robinson, B. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene. 2003; 22:1358-64. [Abstract]
  • Bernard, M., Sidhu, S., Berger, N., Peix, J., Marsh, D., Robinson, B., Gaston, V., Le Bouc, Y., Gicquel, C. A case report in favor of a multistep adrenocortical tumorigenesis. The Journal of clinical endocrinology and metabolism. 2003; 88:998-1001. [Abstract]
  • Messina, M., Yu, D., Both, G., Molloy, P., Robinson, B. Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells. The Journal of clinical endocrinology and metabolism. 2003; 88:1310-1318. [Abstract]
  • Hammett, R., Robinson, B. Responses to access block in Australia: Royal North Shore Hospital. The Medical journal of Australia. 2003; 178:105-107. [Abstract]
  • Sidhu, S., Giquel, C., Bambach, C., Campbell, P., Magarey, C., Robinson, B., Delbridge, L. Clinical and molecular aspects of adrenocortical tumourigenesis. Anz Journal Of Surgery. 2003; 73:727-738.
  • Robinson, B. Gene discovery in endorinology. Current Opinion in Endocrinology and Diabetes. 2003; 10:.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. The Journal of clinical endocrinology and metabolism. 2003; 88:354-7. [Abstract]
  • Cooper, L., Clifton Bligh, R., Nery, M., Figtree, G., Hibbert, E., Twigg, S., Robinson, B. Vitamin D supplementation and bone mineral density in early postmenopausal women. American Journal Of Clinical Nutrition. 2003; 77(5):1324-1329.